ADC Therapeutics SA
NYSE:ADCT
ADC Therapeutics SA
NYSE:ADCT
Price:
4.72 USD
-0.84%
Market Closed
Updated:
Apr 20, 2024
ADC Therapeutics SA
Cash from Investing Activities
Last
Value
3-Years CAGR
5-Years CAGR
|
ADC Therapeutics SA
Cash from Investing Activities Peer Comparison
Comparables:
ACIU
CRSP
BSLN
IDIA
KURN
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
ADC Therapeutics SA
NYSE:ADCT
|
Cash from Investing Activities
$-2.5m
|
CAGR 3-Years
4%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
AC Immune SA
NASDAQ:ACIU
|
Cash from Investing Activities
CHf65.6m
|
CAGR 3-Years
32%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Cash from Investing Activities
$374.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Cash from Investing Activities
CHf-1m
|
CAGR 3-Years
69%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
30%
|
|
|
Idorsia Ltd
SIX:IDIA
|
Cash from Investing Activities
CHf743.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Kuros Biosciences AG
SIX:KURN
|
Cash from Investing Activities
CHf-326k
|
CAGR 3-Years
-14%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
See Also
What is ADC Therapeutics SA's Cash from Investing Activities?
Cash from Investing Activities
-2.5m
USD
-2.5m
USD
Based on the financial report for Dec 31, 2023, ADC Therapeutics SA's Cash from Investing Activities amounts to -2.5m USD.
What is ADC Therapeutics SA's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
0%
0%
Over the last year, the Cash from Investing Activities growth was 0%. The average annual Cash from Investing Activities growth rates for ADC Therapeutics SA have been 4% over the past three years .
You don't have any saved screeners yet
